Sort
30,917 grants matching “tumor microenvironment”
CD19 Directed CAR Therapy
$237,659Carl H. June · University Of Pennsylvania · R01 · FY2016 · CA
Histotripsy as a novel limb salvage treatment and immunotherapy for osteosarcoma
$237,547Joanne Tuohy · Virginia Polytechnic Inst And St Univ · R21 · FY2020 · EB
Angiogenesis antagonist plus CD40-TLR agonist adjuvant combination vaccine
$237,514Susan Dana Jones · Immurx Llc · R43 · FY2011 · AI
Core 2: Stanford Breast Metastasis Center Organoid Core
$237,505Calvin J Kuo · Stanford University · U54 · FY2022 · CA
Define the role of REV-ERB in colonic RORgt+ regulatory T cells
$237,500Ye Zheng · Salk Institute For Biological Studies · R21 · FY2024 · AI
Histotripsy as a novel limb salvage treatment and immunotherapy for osteosarcoma
$237,473Joanne Tuohy · Virginia Polytechnic Inst And St Univ · R21 · FY2021 · EB
Tumor microenvironment-targeted theranostic paramagnetic probes
$237,459Andrey Bobko · West Virginia University · P20 · FY2020 · GM
Mechanisms of Disseminated Tumor Cell Dormancy
$237,439Julio A Aguirre-Ghiso · Albert Einstein College Of Medicine · U54 · FY2012 · CA
Pathogenic Lymphocytes in Lupus Nephritis
$237,413Joseph E Craft · Yale University · R21 · FY2019 · AI
Project 4: Understanding and Optimizing Vascular Response to
$237,308Theresa M Busch · University Of Pennsylvania · P01 · FY2015 · CA
HDM2 as a Therapeutic Target in RCC
$237,240James W Mier · Beth Israel Deaconess Medical Center · P50 · FY2017 · CA
Cancer Research Training and Education Coordination
$237,218Yves A Declerck · University Of Southern California · P30 · FY2024 · CA
The role of esophageal myofibroblasts in alcohol related esophageal squamous cell carcinoma.
$237,188Anisa Shaker · University Of Southern California · R21 · FY2021 · AA
Project 1
$237,175Elsa R Flores · H. Lee Moffitt Cancer Ctr & Res Inst · P01 · FY2021 · CA
Project 1
$237,173Elsa R Flores · H. Lee Moffitt Cancer Ctr & Res Inst · P01 · FY2025 · CA
Microenvironmental Transport for Immunotherapy in Pancreatic Cancer
$237,169Rolf A Brekken · Methodist Hospital Research Institute · U54 · FY2019 · CA
Core Support for Cancer Center
$237,147Edward Chu · Albert Einstein College Of Medicine · P30 · FY2021 · CA
The Aged Microenvironment as a Contributor to Carcinogenesis
$237,119Judith Campisi · University Of Washington · U54 · FY2010 · CA
DKK as a Key Regulator of Prostate Cancer Bone Metastasis
$237,113Evan Todd Keller · University Of Michigan At Ann Arbor · P01 · FY2010 · CA
Fatty Acid Synthase in Prostate Tumorigenesis
$237,091University Of Pittsburgh At Pittsburgh · R01 · FY2004 · CA
Immune Monitoring and Tissue Analysis
$237,051Martin Felices · University Of Minnesota · P01 · FY2022 · CA
Identifying novel resistance mechanisms in non-muscle invasive bladder cancer treated with Bacillus Calmette-Guerin (BCG)
$237,023John Sfakianos · Icahn School Of Medicine At Mount Sinai · R21 · FY2023 · CA
Targeting the Androgen Receptor to Sensitize Bladder Cancer to Immune Check Point Blockade.
$237,023David Mulholland · Icahn School Of Medicine At Mount Sinai · R21 · FY2024 · CA
Ubiquitin ligase regulation of tissue-resident T cell and anti-tumor activity
$237,000Ananda W Goldrath · University Of California, San Diego · R21 · FY2023 · AI
Mechanism of SPARC peptide FSEC inhibition of angiogenesis in neuroblastoma
$237,000Susan L Cohn · University Of Chicago · R21 · FY2013 · NS